Minghui Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- Mitochondrial Function and Pathology
Papers in
-
- Circular RNAs in diseases 3
- Congenital heart defects research 2
-
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Tiansong Xia (8 shared papers)Shui Wang (6 shared papers)Wei Zhu (4 shared papers)Xin Zhou (4 shared papers)Yao‐Jun Zhang (5 shared papers)Javaid Iqbal (5 shared papers)Shao‐Liang Chen (6 shared papers)Zebo Huang (3 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (4 papers)BMC Cardiovascular Disorders (3 papers)Breast Cancer Research and Treatment (2 papers)Circulation Research (2 papers)Cancer Biomarkers (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Minghui Li
42 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 389
- Molecular Biology 749
- Cardiology and Cardiovascular Medicine 171
- Pharmacology 94
- Geriatrics and Gerontology 16
Countries citing papers authored by Minghui Li
This map shows the geographic impact of Minghui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghui Li more than expected).
Fields of papers citing papers by Minghui Li
This network shows the impact of papers produced by Minghui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghui Li. The network helps show where Minghui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Minghui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 115 | |
| 2 | 2018 | 109 | |
| 3 | 2014 | 108 | |
| 4 | 2019 | 77 | |
| 5 | 2013 | 63 | |
| 6 | 2014 | 60 | |
| 7 | 2020 | 59 | |
| 8 | 2021 | 52 | |
| 9 | 2020 | 50 | |
| 10 | 2020 | 50 | |
| 11 | 2012 | 44 | |
| 12 | 2017 | 41 | |
| 13 | 2015 | 40 | |
| 14 | 2024 | 34 | |
| 15 | 2020 | 32 | |
| 16 | 2016 | 31 | |
| 17 | Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1. | 2015 | 27 |
| 18 | 2023 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2019 | 21 |
About Minghui Li
Minghui Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Autophagy in Disease and Therapy (3 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Congenital heart defects research (2 papers). The work is most often cited by research in Cancer Research (389 citations), Molecular Biology (749 citations), Cardiology and Cardiovascular Medicine (171 citations), Pharmacology (94 citations) and Geriatrics and Gerontology (16 citations). Minghui Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Tiansong Xia, Shui Wang, Wei Zhu, Xin Zhou, Yao‐Jun Zhang, Javaid Iqbal, Shao‐Liang Chen, Zebo Huang, Zhimei Wang and Tongshan Wang. Their work appears in journals such as Journal of Cardiovascular Pharmacology, BMC Cardiovascular Disorders, Breast Cancer Research and Treatment, Circulation Research and Cancer Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.